Smith, Moore & Co’s Cigna CI Stock Holding History

Smith, Moore & Co’s Portfolio CI Stock Details CI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$465K	Sell	1,689 -124	-7%	-$35K	0.03%	371
2026 Q1	$484K	Buy	+1,813	New	+$502K	0.04%	336
2020 Q3	–	Sell	-2,019	Closed	-$379K	–	327
2020 Q2	$379K	Buy	2,019 +203	+11%	+$38.5K	0.08%	214
2020 Q1	$322K	Buy	1,816 +318	+21%	+$61.7K	0.08%	208
2019 Q4	$306K	Sell	1,498 -389	-21%	-$71.3K	0.06%	253
2019 Q3	$286K	Buy	1,887 +46	+2%	+$7.49K	0.06%	252
2019 Q2	$290K	Buy	1,841 +41	+2%	+$6.42K	0.07%	265
2019 Q1	$289K	Buy	1,800 +51	+3%	+$9.31K	0.07%	250
2018 Q4	$332K	Buy	+1,749	New	+$365K	0.09%	213
2018 Q1	–	Sell	-1,422	Closed	-$289K	–	328
2017 Q4	$289K	Sell	1,422 -183	-11%	-$36.4K	0.08%	227
2017 Q3	$300K	Buy	1,605 +68	+4%	+$12.1K	0.09%	223
2017 Q2	$257K	Buy	1,537 +161	+12%	+$25.9K	0.09%	205
2017 Q1	$202K	Buy	+1,376	New	+$203K	0.07%	225

Other funds holding CI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Smith, Moore & Co's CI Position: Q2 2026 in Review

Smith, Moore & Co reduced its Cigna (CI) stake by 6.8% in Q2 2026, selling an estimated $35K and leaving 1,689 shares worth $465K. The position accounts for 0.03% of the portfolio, ranked #371.

Smith, Moore & Co first reported a position in CI in Q1 2017 and has held it in 13 quarters since. The position peaked at $484K in Q1 2026. 1,705 funds tracked by Wall St. Rank hold CI as of Q2 2026.

Smith, Moore & Co held 1,689 shares of Cigna worth $465K as of Q2 2026.
Smith, Moore & Co sold 124 Cigna shares in Q2 2026, an estimated $35K.
Cigna made up 0.03% of Smith, Moore & Co's portfolio in Q2 2026, its #371 holding.
Smith, Moore & Co first reported a position in Cigna in Q1 2017 and has held it in 13 quarters since.
Smith, Moore & Co's Cigna position peaked at $484K in Q1 2026.
1,705 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Smith, Moore & Co's 13F filing for Q2 2026, filed 12 Aug 2026.